Oscar Hoiting

Nijmegen, GE, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Influenza-associated invasive aspergillosis in the ICU: a prospective, multicentre cohort study.

Influenza-associated invasive aspergillosis in the ICU: a prospective, multicentre cohort study.

Journal: Critical care (London, England)

Published: July 13, 2025

Influenza-associated invasive aspergillosis in the ICU: a prospective, multicentre cohort study.

Influenza-associated invasive aspergillosis in the ICU: a prospective, multicentre cohort study.

Journal: Critical care (London, England)

Published: July 13, 2025

Safety and Outcome of High-Flow Nasal Oxygen Therapy Outside ICU Setting in Hypoxemic Patients With COVID-19.

Safety and Outcome of High-Flow Nasal Oxygen Therapy Outside ICU Setting in Hypoxemic Patients With COVID-19.

Journal: Critical care medicine

Published: October 19, 2023

Time spent on documenting quality indicator data and associations between the perceived burden of documenting these data and joy in work among professionals in intensive care units in the Netherlands: a multicentre cross-sectional survey.

Time spent on documenting quality indicator data and associations between the perceived burden of documenting these data and joy in work among professionals in intensive care units in the Netherlands: a multicentre cross-sectional survey.

Journal: BMJ open

Published: March 06, 2023

Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial.

Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial.

Journal: Intensive care medicine

Published: May 12, 2021

Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial.

Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial.

Journal: Intensive care medicine

Published: March 08, 2021

COVID-19-associated pulmonary aspergillosis: a prospective single-center dual case series.

COVID-19-associated pulmonary aspergillosis: a prospective single-center dual case series.

Journal: Mycoses

Published: February 01, 2021

Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.

Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.

Journal: JAMA

Published: September 03, 2020

Breath-synchronized electrical stimulation of the expiratory muscles in mechanically ventilated patients: a randomized controlled feasibility study and pooled analysis.

Breath-synchronized electrical stimulation of the expiratory muscles in mechanically ventilated patients: a randomized controlled feasibility study and pooled analysis.

Journal: Critical care (London, England)

Published: July 27, 2020

Azole-Resistant COVID-19-Associated Pulmonary Aspergillosis in an Immunocompetent Host: A Case Report.

Azole-Resistant COVID-19-Associated Pulmonary Aspergillosis in an Immunocompetent Host: A Case Report.

Journal: Journal of fungi (Basel, Switzerland)

Published: May 26, 2020

Prevalence and management of delirium in intensive care units in the Netherlands: An observational multicentre study.

Prevalence and management of delirium in intensive care units in the Netherlands: An observational multicentre study.

Journal: Intensive & critical care nursing

Published: December 19, 2019

A multicenter, randomized, double-blind study of ulimorelin and metoclopramide in the treatment of critically ill patients with enteral feeding intolerance: PROMOTE trial.

A multicenter, randomized, double-blind study of ulimorelin and metoclopramide in the treatment of critically ill patients with enteral feeding intolerance: PROMOTE trial.

Journal: Intensive care medicine

Published: December 12, 2018

Showing 1-12 of 13

Last Updated: 09/26/2026